175 related articles for article (PubMed ID: 28435462)
1. A Programmed Nanoparticle with Self-Adapting for Accurate Cancer Cell Eradication and Therapeutic Self-Reporting.
Luo Y; Huang L; Yang Y; Zhuang X; Hu S; Ju H; Yu BY; Tian J
Theranostics; 2017; 7(5):1245-1256. PubMed ID: 28435462
[TBL] [Abstract][Full Text] [Related]
2. Redox Dual-Responsive and O
Chen H; Li F; Yao Y; Wang Z; Zhang Z; Tan N
Theranostics; 2019; 9(1):90-103. PubMed ID: 30662556
[TBL] [Abstract][Full Text] [Related]
3. Quantitative imaging of intracellular nanoparticle exposure enables prediction of nanotherapeutic efficacy.
Yin Q; Pan A; Chen B; Wang Z; Tang M; Yan Y; Wang Y; Xia H; Chen W; Du H; Chen M; Fu C; Wang Y; Yuan X; Lu Z; Zhang Q; Wang Y
Nat Commun; 2021 Apr; 12(1):2385. PubMed ID: 33888701
[TBL] [Abstract][Full Text] [Related]
4. Self-Monitoring and Self-Delivery of Photosensitizer-Doped Nanoparticles for Highly Effective Combination Cancer Therapy in Vitro and in Vivo.
Zhang J; Liang YC; Lin X; Zhu X; Yan L; Li S; Yang X; Zhu G; Rogach AL; Yu PK; Shi P; Tu LC; Chang CC; Zhang X; Chen X; Zhang W; Lee CS
ACS Nano; 2015 Oct; 9(10):9741-56. PubMed ID: 26390118
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence optical imaging in anticancer drug delivery.
Etrych T; Lucas H; Janoušková O; Chytil P; Mueller T; Mäder K
J Control Release; 2016 Mar; 226():168-81. PubMed ID: 26892751
[TBL] [Abstract][Full Text] [Related]
6. ATP-Responsive and Near-Infrared-Emissive Nanocarriers for Anticancer Drug Delivery and Real-Time Imaging.
Qian C; Chen Y; Zhu S; Yu J; Zhang L; Feng P; Tang X; Hu Q; Sun W; Lu Y; Xiao X; Shen QD; Gu Z
Theranostics; 2016; 6(7):1053-64. PubMed ID: 27217838
[TBL] [Abstract][Full Text] [Related]
7. A ratiometric theranostic probe for tumor targeting therapy and self-therapeutic monitoring.
Li SY; Cheng H; Xie BR; Qiu WX; Song LL; Zhuo RX; Zhang XZ
Biomaterials; 2016 Oct; 104():297-309. PubMed ID: 27475726
[TBL] [Abstract][Full Text] [Related]
8. Metal nanoparticles: a theranostic nanotool against cancer.
Sharma H; Mishra PK; Talegaonkar S; Vaidya B
Drug Discov Today; 2015 Sep; 20(9):1143-51. PubMed ID: 26007605
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Fluorescent Hybrid Nanoparticles for Traceable Delivery of Glucocorticoids to Inflammatory Sites.
Napp J; Markus MA; Heck JG; Dullin C; Möbius W; Gorpas D; Feldmann C; Alves F
Theranostics; 2018; 8(22):6367-6383. PubMed ID: 30613305
[TBL] [Abstract][Full Text] [Related]
10. Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy.
Gao M; Yu F; Lv C; Choo J; Chen L
Chem Soc Rev; 2017 Apr; 46(8):2237-2271. PubMed ID: 28319221
[TBL] [Abstract][Full Text] [Related]
11. Cancer Theranostic Nanoparticles Self-Assembled from Amphiphilic Small Molecules with Equilibrium Shift-Induced Renal Clearance.
Ma Y; Mou Q; Sun M; Yu C; Li J; Huang X; Zhu X; Yan D; Shen J
Theranostics; 2016; 6(10):1703-16. PubMed ID: 27446502
[TBL] [Abstract][Full Text] [Related]
12. The role of nanoparticles in the improvement of systemic anticancer drug delivery.
Field LD; Nag OK; Sangtani A; Burns KE; Delehanty JB
Ther Deliv; 2018 Jul; 9(7):527-545. PubMed ID: 29943689
[TBL] [Abstract][Full Text] [Related]
13. Engineering Circulating Tumor Cells as Novel Cancer Theranostics.
Parkins KM; Dubois VP; Kelly JJ; Chen Y; Knier NN; Foster PJ; Ronald JA
Theranostics; 2020; 10(17):7925-7937. PubMed ID: 32685030
[TBL] [Abstract][Full Text] [Related]
14. A Glutathione (GSH)-Responsive Near-Infrared (NIR) Theranostic Prodrug for Cancer Therapy and Imaging.
Kong F; Liang Z; Luan D; Liu X; Xu K; Tang B
Anal Chem; 2016 Jun; 88(12):6450-6. PubMed ID: 27216623
[TBL] [Abstract][Full Text] [Related]
15. Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.
Durymanov MO; Rosenkranz AA; Sobolev AS
Theranostics; 2015; 5(9):1007-20. PubMed ID: 26155316
[TBL] [Abstract][Full Text] [Related]
16. A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.
Cui L; Lin Q; Jin CS; Jiang W; Huang H; Ding L; Muhanna N; Irish JC; Wang F; Chen J; Zheng G
ACS Nano; 2015; 9(4):4484-95. PubMed ID: 25830219
[TBL] [Abstract][Full Text] [Related]
17. Photoinduced Electron Transfer-Based Glutathione-Sensing Theranostic Nanoprodrug with Self-Tracking and Real-Time Drug Release Monitoring for Cancer Treatment.
Nisar S; Starosta E; Elayyan M; Regmi A; Sui B
ACS Appl Mater Interfaces; 2024 Feb; 16(6):6859-6867. PubMed ID: 38299497
[TBL] [Abstract][Full Text] [Related]
18. Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer.
Liu Y; Gunda V; Zhu X; Xu X; Wu J; Askhatova D; Farokhzad OC; Parangi S; Shi J
Proc Natl Acad Sci U S A; 2016 Jul; 113(28):7750-5. PubMed ID: 27342857
[TBL] [Abstract][Full Text] [Related]
19. Core-Shell Nanostars for Multimodal Therapy and Imaging.
Li M; Li L; Zhan C; Kohane DS
Theranostics; 2016; 6(13):2306-2313. PubMed ID: 27877236
[TBL] [Abstract][Full Text] [Related]
20. Gold nanostars for efficient in vitro and in vivo real-time SERS detection and drug delivery via plasmonic-tunable Raman/FTIR imaging.
Tian F; Conde J; Bao C; Chen Y; Curtin J; Cui D
Biomaterials; 2016 Nov; 106():87-97. PubMed ID: 27552319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
